Risks and limits of Abnehmspritze Frauen

The so-called weight loss injection (GLP-1 receptor agonists like semaglutide, liraglutide) is a prescription drug with strong evidence from randomized controlled trials (human-strong) for significant weight reduction. However, there are specific risks and limits for women. Common side effects include nausea, vomiting, diarrhea, and constipation, which may be more pronounced in women. Rare but serious risks include pancreatitis, gallbladder disease, and a potential risk of medullary thyroid carcinoma (C-cell tumors). For women of childbearing age, caution is essential: safety during pregnancy and breastfeeding is not established; contraception is recommended. Additionally, delayed gastric emptying may affect oral contraceptive absorption. The injection is not a magic bullet – effects are dose-dependent and often reversed after discontinuation. Long-term data beyond 2 years are limited. MyBody-X tests do not directly address this; medical supervision is mandatory.